{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:22:56Z","timestamp":1767676976666},"reference-count":32,"publisher":"Hindawi Limited","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1506,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1111\/j.1365-2710.2011.01287.x","type":"journal-article","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T11:38:24Z","timestamp":1310989104000},"page":"286-290","source":"Crossref","is-referenced-by-count":20,"title":["Intravenous immunoglobulin increases plasma viscosity without parallel rise in blood pressure"],"prefix":"10.1155","volume":"37","author":[{"given":"P.","family":"Bentley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rosso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Sadnicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Israeli-Korn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Laffan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2011,7,18]]},"reference":[{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB1|cit1","unstructured":"Marketing Research Bureau 2009 The plasma fractions market in the United States - 2009 http:\/\/www.idealpatientregistry.com\/Ig_Therapy\/Market_Overview.aspx"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","article-title":"Intravenous immunoglobulin: adverse effects and safe administration","volume":"29","author":"Orbach","year":"2005","journal-title":"Clinical Reviews in Allergy and Immunology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/01.WNL.0000074394.15882.83","article-title":"Strokes, thromboembolic events, and IVIg: rare incidents blemish an excellent safety record","volume":"60","author":"Dalakas","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00415-003-1085-1","article-title":"Side effects of intravenous immunoglobulins in neurological autoimmune disorders - a prospective study","volume":"250","author":"Stangel","year":"2003","journal-title":"Journal of Neurology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1365-2133.2006.07390.x","article-title":"Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature","volume":"155","author":"Marie","year":"2006","journal-title":"British Journal of Dermatology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.44.2.223","article-title":"High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events","volume":"44","author":"Dalakas","year":"1994","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3233\/CH-2008-1131","article-title":"Hemorheological changes after intravenous gammaglobulin administration in patients with neurological disorders","volume":"40","author":"Kowal","year":"2008","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/0140-6736(92)90806-E","article-title":"Effect of high-dose intravenous immunoglobulin therapy on blood rheology","volume":"339","author":"Reinhart","year":"1992","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB10|cit10","first-page":"69","article-title":"Plasmapheresis for hyperviscosity syndrome in macroglobulinemia Waldenstr\u00f6m and multiple myeloma: influence on blood rheology and the microcirculation","volume":"119","author":"Reinhart","year":"1992","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-7963(03)00038-5","article-title":"Risks associated with the use of intravenous immunoglobulin","volume":"17","author":"Pierce","year":"2003","journal-title":"Transfusion Medicine Reviews"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archneurol.2010.223","article-title":"Safety and tolerability of immune globulin intravenous in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"67","author":"Donofrio","year":"2010","journal-title":"Archives of Neurology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1212\/WNL.56.4.445","article-title":"Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy","volume":"56","author":"Mendell","year":"2001","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0895-7061(99)00011-4","article-title":"Effect of hematocrit on blood pressure via hyperviscosity","volume":"12","author":"Cinar","year":"1999","journal-title":"American Journal of Hypertension"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0895-7061(00)01260-7","article-title":"Blood viscosity and blood pressure: role of temperature and hyperglycemia","volume":"14","author":"Cinar","year":"2001","journal-title":"American Journal of Hypertension"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/eurheartj\/14.5.597","article-title":"The relationship between blood viscosity and blood pressure in a random sample of the population aged 55 to 74\u2003years","volume":"14","author":"Fowkes","year":"1993","journal-title":"European Heart Journal"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB17|cit17","first-page":"195","article-title":"Hemorheologic alterations in hypertension: chicken or egg?","volume":"21","author":"Meiselman","year":"1999","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3233\/CH-2010-1261","article-title":"Cardiovascular benefits in moderate increases of blood and plasma viscosity surpass those associated with lowering viscosity: experimental and clinical evidence","volume":"44","author":"Salazar V\u00e1zquez","year":"2010","journal-title":"Clinical Hemorheology and Microcirculation"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1161\/CIRCULATIONAHA.105.596189","article-title":"Triggering of acute cardiovascular disease and potential preventive strategies","volume":"114","author":"Tofler","year":"2006","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1212\/01.WNL.0000068335.01620.9D","article-title":"The clinical features of 16 cases of stroke associated with administration of IVIg","volume":"60","author":"Caress","year":"2003","journal-title":"Neurology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1046\/j.1423-0410.1998.7420074.x","article-title":"IVIG adverse reactions: potential role of cytokines and vasoactive substances","volume":"74","author":"Bagdasarian","year":"1998","journal-title":"Vox Sanguinis"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1182\/blood.V84.7.2136.2136","article-title":"Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo","volume":"84","author":"Aukrust","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1160\/TH09-05-0297","article-title":"How much is too much? Interleukin-6 and its signalling in atherosclerosis","volume":"102","author":"Schuett","year":"2009","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1191\/096120301701549705","article-title":"Antiphospholipid antibody levels in intravenous immunoglobulin (IVIg) preparations","volume":"10","author":"Sherer","year":"2001","journal-title":"Lupus"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0140-6736(05)70152-5","article-title":"Homocysteine and stroke: evidence on a causal link from mendelian randomisation","volume":"365","author":"Casas","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.HYP.5.5.757","article-title":"Elevated blood viscosity in patients with borderline essential hypertension","volume":"5","author":"Letcher","year":"1983","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/000331978904000301","article-title":"Is increased plasma viscosity a risk factor for high blood pressure?","volume":"40","author":"Koenig","year":"1989","journal-title":"Angiology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00001721-200106000-00012","article-title":"Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus\u2003<\u200312\u2003h) stroke patients: the West Birmingham stroke project","volume":"12","author":"Lip","year":"2001","journal-title":"Blood Coagulation and Fibrinolysis"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000008040","article-title":"High-dose intravenous immunoglobulin treatment and cerebral vasospasm: a possible mechanism of ischemic encephalopathy?","volume":"41","author":"Sztajzel","year":"1999","journal-title":"European Neurology"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.amjhyper.2005.01.014","article-title":"Plasma viscosity in isolated systolic hypertension: the role of pulse pressure","volume":"18","author":"Ciuffetti","year":"2005","journal-title":"American Journal of Hypertension"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1161\/01.HYP.0000157526.07977.ec","article-title":"Association of blood pressure with blood viscosity in american indians: the strong heart study","volume":"45","author":"de Simone","year":"2005","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2710.2011.01287.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/BF00920238","article-title":"Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo","volume":"13","author":"Ling","year":"1993","journal-title":"Journal of Clinical Immunology"}],"container-title":["Journal of Clinical Pharmacy and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2710.2011.01287.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2710.2011.01287.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T18:04:17Z","timestamp":1671818657000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2710.2011.01287.x"}},"subtitle":["IVIg, viscosity and blood pressure"],"short-title":[],"issued":{"date-parts":[[2011,7,18]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2710.2011.01287.x","relation":{},"ISSN":["0269-4727"],"issn-type":[{"value":"0269-4727","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,18]]}}}